Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving the drugs in different
combinations may kill more tumor cells. It is not yet known whether receiving irinotecan with
fluorouracil and leucovorin is more effective than receiving oxaliplatin with fluorouracil
and leucovorin in treating recurrent metastatic colorectal cancer
PURPOSE: Randomized phase III trial to compare the effectiveness of irinotecan with
oxaliplatin followed by fluorouracil and leucovorin in treating patients with recurrent
metastatic colorectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)